Home»Exposition»URO-1, Inc. Announces US Patent Issuance for Repris™ Bladder Injection System

URO-1, Inc. Announces US Patent Issuance for Repris™ Bladder Injection System

0
Shares
Pinterest Google+
URO-1, Inc. Announces US Patent Issuance for Repris™ Bladder Injection System

WINSTON-SALEM, N.C., May 15, 2019 /PRNewswire/ — URO-1, Inc., an emerging company that develops solutions for office procedures in urology and urogynecology today announced the issuance of US Patent, “Medical Injection Assemblies for OnabotulinumtoxinA Delivery and Methods of Use Thereof….

Previous post

Sangamo Therapeutics Announces Presentations At Upcoming Scientific, Medical And Investor Conferences

Next post

Entravision Appoints Karl Alonso Meyer as Chief Revenue and Product Officer